Muller DRP, Stenvers DJ, Malekzadeh A, Holleman F, Painter RC, Siegelaar SE
Combined with a healthy diet and exercise, Mounjaro can lead to patients losing up to 22.5% of their starting weight (after 72 weeks of treatment on a maintenance dose of 15mg)
Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, et al
Novo's weight loss drug approved by US cardiologists Novo Nordisks Wegovy and Eli Lillys Zepbound are mentioned in new guidelines from US cardiologists as drugs to consider for preventing cardiovascular disease
Glucagon-like peptide-1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP-1 receptors